Exponent (EXPO) Earning Somewhat Positive Press Coverage, Analysis Finds
Headlines about Exponent (NASDAQ:EXPO) have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Exponent earned a media sentiment score of 0.06 on Accern’s scale. Accern also gave media headlines about the business services provider an impact score of 47.7936808515209 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the media headlines that may have impacted Accern’s analysis:
- Professor sets Guinness World Record for periodic table assembly (purdueexponent.org)
- ITaP to pilot suspension program on non-academic apps in class (purdueexponent.org)
- McKewon: Don’t sleep on senior Devine Ozigbo in crowded Husker backfield (purdueexponent.org)
- Purdue returns Papa John’s donation (purdueexponent.org)
- North River Road to be closed due to bridge construction (purdueexponent.org)
EXPO has been the topic of several analyst reports. Cantor Fitzgerald reiterated a “buy” rating and set a $24.00 target price on shares of Exponent in a report on Friday, April 20th. SunTrust Banks upped their target price on Exponent to $23.75 and gave the stock a “buy” rating in a report on Monday, April 23rd. Zacks Investment Research upgraded Exponent from a “hold” rating to a “buy” rating and set a $24.00 target price on the stock in a report on Monday, April 23rd. Finally, ValuEngine upgraded Exponent from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 5th. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. Exponent currently has a consensus rating of “Buy” and an average target price of $34.67.
Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, July 19th. The business services provider reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.03. The firm had revenue of $95.60 million for the quarter, compared to analyst estimates of $89.42 million. Exponent had a return on equity of 20.52% and a net margin of 13.51%. The business’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.51 earnings per share. equities research analysts forecast that Exponent will post 1.27 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 21st. Shareholders of record on Friday, September 7th will be paid a $0.13 dividend. The ex-dividend date is Thursday, September 6th. This represents a $0.52 annualized dividend and a yield of 1.02%. Exponent’s dividend payout ratio is 48.60%.
In other Exponent news, insider Richard Reiss sold 2,236 shares of the company’s stock in a transaction that occurred on Tuesday, July 31st. The stock was sold at an average price of $49.43, for a total value of $110,525.48. Following the sale, the insider now owns 4,054 shares in the company, valued at $200,389.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Debra Zumwalt sold 500 shares of the company’s stock in a transaction that occurred on Friday, May 25th. The shares were sold at an average price of $96.01, for a total value of $48,005.00. Following the completion of the sale, the director now owns 6,940 shares in the company, valued at approximately $666,309.40. The disclosure for this sale can be found here. 2.70% of the stock is owned by corporate insiders.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Featured Article: How to Invest in Marijuana Stocks
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.